The purpose of this observational registry is to prospectively collect procedure efficiency, safety and acute and long term outcome data from catheter ablation procedures as treatment of paroxysmal atrial fibrillation, using the following treatment modalities:

• Cryoballoon ablation
• Manual guided RF ablation using Contact Force catheters
• Remote Magnetic Navigation guided RF ablation with e-Contact and high power settings
• Remote Magnetic Navigation guided RF ablation with e-Contact and low power settings

Inclusion Criteria:

• Documented Paroxysmal Atrial Fibrillation
• Eligibility for Pulmonary Vein Isolation by catheter ablation based on the respective ACC/AHA/ESC Guideline valid at the date of procedure
• Signed the informed consent to participate in the registry

Exclusion Criteria:

• Younger than 18 years of age
• Prior AF ablation procedure (including MAZE procedure)
• Prior ablation of Non-AF Arrhythmia within 3 months of enrollment
• Presence of cardiac thrombus
• Other AF ablations performed during procedure (e.g. lines, rotor, CFAE's etc)
• Active endocarditis or systemic infection
• Life expectancy < 1 year
• Pregnancy

Patients eligible for participation in the study have a reported incidence of at least two documented episodes of symptomatic paroxysmal atrial fibrillation during the three months preceding trial entry, as well as documentation of at least one episode of AF on ECG, and are eligible for PVI by catheter ablation based on the respective ACC/AHA/ESC Guideline valid at the date of procedure